These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 18974106)
21. Selective inhibition of ErbB2-overexpressing breast cancer in vivo by a novel TAT-based ErbB2-targeting signal transducers and activators of transcription 3-blocking peptide. Tan M; Lan KH; Yao J; Lu CH; Sun M; Neal CL; Lu J; Yu D Cancer Res; 2006 Apr; 66(7):3764-72. PubMed ID: 16585203 [TBL] [Abstract][Full Text] [Related]
22. RNA interference targeting Stat3 inhibits growth and induces apoptosis of human prostate cancer cells. Lee SO; Lou W; Qureshi KM; Mehraein-Ghomi F; Trump DL; Gao AC Prostate; 2004 Sep; 60(4):303-9. PubMed ID: 15264241 [TBL] [Abstract][Full Text] [Related]
23. Stat3 activation is required for cell proliferation and tumorigenesis but not for cell viability in cutaneous squamous cell carcinoma cell lines. Sumita N; Bito T; Nakajima K; Nishigori C Exp Dermatol; 2006 Apr; 15(4):291-9. PubMed ID: 16512876 [TBL] [Abstract][Full Text] [Related]
24. Constitutive activation of Stat3 in human prostate tumors and cell lines: direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells. Mora LB; Buettner R; Seigne J; Diaz J; Ahmad N; Garcia R; Bowman T; Falcone R; Fairclough R; Cantor A; Muro-Cacho C; Livingston S; Karras J; Pow-Sang J; Jove R Cancer Res; 2002 Nov; 62(22):6659-66. PubMed ID: 12438264 [TBL] [Abstract][Full Text] [Related]
25. Cyclin D1 is transcriptionally regulated by and required for transformation by activated signal transducer and activator of transcription 3. Leslie K; Lang C; Devgan G; Azare J; Berishaj M; Gerald W; Kim YB; Paz K; Darnell JE; Albanese C; Sakamaki T; Pestell R; Bromberg J Cancer Res; 2006 Mar; 66(5):2544-52. PubMed ID: 16510571 [TBL] [Abstract][Full Text] [Related]
26. Inhibition of growth and metastasis of human hepatocellular carcinoma by antisense oligonucleotide targeting signal transducer and activator of transcription 3. Li WC; Ye SL; Sun RX; Liu YK; Tang ZY; Kim Y; Karras JG; Zhang H Clin Cancer Res; 2006 Dec; 12(23):7140-8. PubMed ID: 17145839 [TBL] [Abstract][Full Text] [Related]
27. Stem-cell protein Piwil2 is widely expressed in tumors and inhibits apoptosis through activation of Stat3/Bcl-XL pathway. Lee JH; Schütte D; Wulf G; Füzesi L; Radzun HJ; Schweyer S; Engel W; Nayernia K Hum Mol Genet; 2006 Jan; 15(2):201-11. PubMed ID: 16377660 [TBL] [Abstract][Full Text] [Related]
28. Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells. Gritsko T; Williams A; Turkson J; Kaneko S; Bowman T; Huang M; Nam S; Eweis I; Diaz N; Sullivan D; Yoder S; Enkemann S; Eschrich S; Lee JH; Beam CA; Cheng J; Minton S; Muro-Cacho CA; Jove R Clin Cancer Res; 2006 Jan; 12(1):11-9. PubMed ID: 16397018 [TBL] [Abstract][Full Text] [Related]
29. Inhibition of Stat3 increases doxorubicin sensitivity in a human metastatic breast cancer cell line. Gariboldi MB; Ravizza R; Molteni R; Osella D; Gabano E; Monti E Cancer Lett; 2007 Dec; 258(2):181-8. PubMed ID: 17920763 [TBL] [Abstract][Full Text] [Related]
30. Galiellalactone is a novel therapeutic candidate against hormone-refractory prostate cancer expressing activated Stat3. Hellsten R; Johansson M; Dahlman A; Dizeyi N; Sterner O; Bjartell A Prostate; 2008 Feb; 68(3):269-80. PubMed ID: 18163422 [TBL] [Abstract][Full Text] [Related]
31. Activated signal transducers and activators of transcription 3 signaling induces CD46 expression and protects human cancer cells from complement-dependent cytotoxicity. Buettner R; Huang M; Gritsko T; Karras J; Enkemann S; Mesa T; Nam S; Yu H; Jove R Mol Cancer Res; 2007 Aug; 5(8):823-32. PubMed ID: 17699108 [TBL] [Abstract][Full Text] [Related]
32. Interleukin-24 induces expression of beta4 integrin but suppresses anchorage-independent growth of rat mammary tumor cells by a mechanism that is independent of beta4. Xuan W; Li YJ; Liu G; Ben-David Y; Archer MC Mol Cancer Res; 2009 Mar; 7(3):433-42. PubMed ID: 19258414 [TBL] [Abstract][Full Text] [Related]
33. Cyclin D1 overexpression and response to bortezomib treatment in a breast cancer model. Ishii Y; Pirkmaier A; Alvarez JV; Frank DA; Keselman I; Logothetis D; Mandeli J; O'Connell MJ; Waxman S; Germain D J Natl Cancer Inst; 2006 Sep; 98(17):1238-47. PubMed ID: 16954476 [TBL] [Abstract][Full Text] [Related]
34. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments]. Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094 [TBL] [Abstract][Full Text] [Related]
35. Knockdown of STAT3 expression by RNAi suppresses growth and induces apoptosis and differentiation in glioblastoma stem cells. Li GH; Wei H; Lv SQ; Ji H; Wang DL Int J Oncol; 2010 Jul; 37(1):103-10. PubMed ID: 20514402 [TBL] [Abstract][Full Text] [Related]
36. Inhibition of gp130 signaling in breast cancer blocks constitutive activation of Stat3 and inhibits in vivo malignancy. Selander KS; Li L; Watson L; Merrell M; Dahmen H; Heinrich PC; Müller-Newen G; Harris KW Cancer Res; 2004 Oct; 64(19):6924-33. PubMed ID: 15466183 [TBL] [Abstract][Full Text] [Related]
37. Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancer. Duan Z; Foster R; Bell DA; Mahoney J; Wolak K; Vaidya A; Hampel C; Lee H; Seiden MV Clin Cancer Res; 2006 Sep; 12(17):5055-63. PubMed ID: 16951221 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of potential Stat3-regulated genes in human breast cancer. Hsieh FC; Cheng G; Lin J Biochem Biophys Res Commun; 2005 Sep; 335(2):292-9. PubMed ID: 16081048 [TBL] [Abstract][Full Text] [Related]
39. The role of constitutively active signal transducer and activator of transcription 3 in ovarian tumorigenesis and prognosis. Rosen DG; Mercado-Uribe I; Yang G; Bast RC; Amin HM; Lai R; Liu J Cancer; 2006 Dec; 107(11):2730-40. PubMed ID: 17063503 [TBL] [Abstract][Full Text] [Related]
40. Rapamycin causes poorly reversible inhibition of mTOR and induces p53-independent apoptosis in human rhabdomyosarcoma cells. Hosoi H; Dilling MB; Shikata T; Liu LN; Shu L; Ashmun RA; Germain GS; Abraham RT; Houghton PJ Cancer Res; 1999 Feb; 59(4):886-94. PubMed ID: 10029080 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]